Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
26 Mar 2024 |
AP01 |
Appointment of Mr Nicholas Ettery as a director on 23 February 2024
|
|
|
11 Mar 2024 |
TM01 |
Termination of appointment of Giancarlo Notarianni as a director on 23 February 2024
|
|
|
08 Jan 2024 |
AA |
Full accounts made up to 31 December 2022
|
|
|
05 Oct 2023 |
CS01 |
Confirmation statement made on 30 September 2023 with no updates
|
|
|
16 Aug 2023 |
PSC05 |
Change of details for Mercury Pharma Group Limited as a person with significant control on 1 August 2023
|
|
|
03 Aug 2023 |
CH01 |
Director's details changed for Mr Vikram Laxman Kamath on 31 July 2023
|
|
|
03 Aug 2023 |
CH01 |
Director's details changed for Giancarlo Notarianni on 31 July 2023
|
|
|
03 Aug 2023 |
CH01 |
Director's details changed for Mr Francisco Javier Barcelo Sanchez on 31 July 2023
|
|
|
02 Aug 2023 |
CH01 |
Director's details changed for Mr Vikram Laxman Kamath on 1 October 2022
|
|
|
01 Aug 2023 |
AD01 |
Registered office address changed from Capital House 85 King William Street London EC4N 7BL United Kingdom to Dashwood House 69 Old Broad Street London EC2M 1QS on 1 August 2023
|
|
|
04 May 2023 |
AA |
Full accounts made up to 31 December 2021
|
|
|
22 Mar 2023 |
CH01 |
Director's details changed for Giancarlo Notarianni on 26 September 2022
|
|
|
07 Nov 2022 |
CS01 |
Confirmation statement made on 30 September 2022 with updates
|
|
|
26 Sep 2022 |
AD01 |
Registered office address changed from Capital House Capital House 85 King William Street London EC4N 7BL England to Capital House 85 King William Street London EC4N 7BL on 26 September 2022
|
|
|
26 Sep 2022 |
AD01 |
Registered office address changed from One Glass Wharf Bristol BS2 0ZX United Kingdom to Capital House Capital House 85 King William Street London EC4N 7BL on 26 September 2022
|
|
|
26 Sep 2022 |
CERTNM |
Company name changed intercept pharma LTD\certificate issued on 26/09/22
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2022-09-26
|
|
|
22 Jul 2022 |
AD01 |
Registered office address changed from Capital House 85 King William Street London EC4N 7BL England to One Glass Wharf Bristol BS2 0ZX on 22 July 2022
|
|
|
20 Jul 2022 |
CH01 |
Director's details changed for Mr Francisco Barcelo Sanchez on 20 July 2022
|
|
|
20 Jul 2022 |
TM01 |
Termination of appointment of Rocco Venezia as a director on 1 July 2022
|
|
|
05 Jul 2022 |
AD01 |
Registered office address changed from One Glass Wharf Bristol BS2 0ZX United Kingdom to Capital House 85 King William Street London EC4N 7BL on 5 July 2022
|
|
|
04 Jul 2022 |
PSC02 |
Notification of Mercury Pharma Group Limited as a person with significant control on 1 July 2022
|
|
|
04 Jul 2022 |
PSC07 |
Cessation of Intercept Pharmaceuticals, Inc. as a person with significant control on 1 July 2022
|
|
|
04 Jul 2022 |
AP01 |
Appointment of Mr Francisco Barcelo Sanchez as a director on 1 July 2022
|
|
|
04 Jul 2022 |
AP01 |
Appointment of Mr Vikram Laxman Kamath as a director on 1 July 2022
|
|
|
04 Jul 2022 |
TM01 |
Termination of appointment of Graham Charles Higson as a director on 1 July 2022
|
|